论文部分内容阅读
糖尿病视网膜病变(diabetic retinopathy,DR)是糖尿病常见的眼部并发症,其治疗包括眼部治疗及系统综合性治疗。眼部治疗手段有视网膜激光光凝术、玻璃体腔注射激素类药物、玻璃体切除术、玻璃体腔注射抗血管内皮生长因子(vascular endothelial growth factor,VEGF)类药物,如今最为热门的是玻璃体腔注射抗VEGF类药物。以上不同的治疗手段在DR不同病程阶段的应用处于不断的更新和探索中。该文就抗VEGF时代DR的治疗演变及目前存在的争议进行综述。
Diabetic retinopathy (diabetic retinopathy, DR) is a common eye complications of diabetes, its treatment, including eye treatment and systemic treatment. Eye treatment of retinal laser photocoagulation, vitreous cavity injection of hormone drugs, vitrectomy, intravitreal injection of anti-vascular endothelial growth factor (VEGF) drugs, the most popular is the vitreous cavity injection VEGF drugs. The above different treatment methods in the application of different stages of DR are constantly updated and explored. This review summarizes the evolution of the treatment of DR in the anti-VEGF era and the current controversies.